Skip to main content
رجوع
MGTX logo

MeiraGTx Holdings plc

جودة البيانات: 100%
MGTX
NASDAQ Healthcare Biotechnology
KWD 7.65
▲ KWD 0.45 (6.25%)
القيمة السوقية: 615.76M
نطاق اليوم
KWD 7.38 KWD 7.71
نطاق 52 أسبوعًا
KWD 4.55 KWD 9.73
حجم التداول
330,238
متوسط 50 يوم / 200 يوم
KWD 7.56 / KWD 7.81
الإغلاق السابق
KWD 7.20

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E -4.2 0.4
P/B 9.1 2.9
ROE % -143.5 3.7
Net Margin % -444.1 3.9
Rev Growth 5Y % 20.9 10.0
D/E 1.3 0.2

السعر المستهدف للمحللين

Hold
KWD 18.000 +135.3%
Low: KWD 16.000 High: KWD 20.000
ربحية السهم المستقبلية
-KWD 1.129
الإيرادات المقدّرة
120 M

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2029 KWD 0.603
-KWD 0.153 – KWD 1.109
360 M 1
FY2028 -KWD 0.543
-KWD 1.460 – KWD 0.800
210 M 3
FY2027 -KWD 0.817
-KWD 2.140 – KWD 0.360
150 M 3

النقاط الرئيسية

Revenue grew 20.93% annually over 5 years — strong growth
Negative free cash flow of -109.45M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 116.49%

النمو

Revenue Growth (5Y)
20.93%
Revenue (1Y)137.42%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-143.48%
ROIC-80.69%
Net Margin-444.10%
Op. Margin-493.44%

الأمان

Debt / Equity
1.25
Current Ratio2.03
Interest Coverage-12.37

التقييم

P/E Ratio
-4.17
P/B Ratio9.08
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 137.42% Revenue Growth (3Y) 44.58%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 20.93% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 33.28M Net Income (TTM) -147.79M
ROE -143.48% ROA -54.79%
Gross Margin 28.51% Operating Margin -493.44%
Net Margin -444.10% Free Cash Flow (TTM) -109.45M
ROIC -80.69% FCF Growth (3Y) N/A
Safety
Debt / Equity 1.25 Current Ratio 2.03
Interest Coverage -12.37 Dividend Yield 0.00%
Valuation
P/E Ratio -4.17 P/B Ratio 9.08
P/S Ratio 18.50 PEG Ratio -0.07
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 615.76M Enterprise Value 596.89M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 33.28M 14.02M 15.92M 37.70M 15.56M
Net Income -147.79M -84.03M -129.62M -79.56M -57.99M
EPS (Diluted) -2.12 -1.49 -3.16 -1.63 -1.43
Gross Profit 9.49M 14.02M 15.92M 37.70M 15.56M
Operating Income -164.21M -137.06M -116.36M -72.76M -62.55M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 269.75M 326.74M 318.24M 320.16M 363.70M
Total Liabilities 201.92M 188.57M 200.50M 134.76M 125.14M
Shareholders' Equity 67.83M 138.18M 117.74M 185.40M 238.56M
Total Debt 84.80M 89.26M 92.25M 23.73M 22.25M
Cash & Equivalents 103.66M 129.57M 115.52M 137.70M 209.52M
Current Assets 123.52M 159.62M 154.34M 183.24M 272.58M
Current Liabilities 60.78M 67.08M 82.07M 68.13M 54.15M